null

GenieFluor 488 Anti-Human CD38 Antibody [HIT2] (AGEL0248)

SKU:
AGEL0248
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Host Species:
Mouse
Isotype:
IgG1
Clone:
HIT2
Conjugation:
AF 488
Applications:
FC
$251 - $851
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

GenieFluor 488 Anti-Human CD38 Antibody [HIT2]

The Human CD38 Monoclonal Antibody (Alexa Fluor 488 Conjugated, HIT2) - AGEL0248 is an essential tool for researchers investigating CD38, a transmembrane glycoprotein involved in various cellular processes such as cell adhesion, signaling, and calcium signaling. This antibody, a monoclonal clone that specifically targets human CD38, is conjugated with Alexa Fluor 488 for fluorescent detection applications.CD38 is a multifunctional protein known for its roles in immune regulation, cell activation, and differentiation. It is expressed on a variety of cell types, including immune cells, endothelial cells, and neurons. The CD38 Monoclonal Antibody offers high specificity and sensitivity in detecting CD38 expression, providing valuable insights into its localization and function within different cell populations.Researchers studying immunology, oncology, and neurobiology can benefit from the CD38 Monoclonal Antibody for visualizing and quantifying CD38 levels in different experimental contexts.

Whether investigating immune cell function, tumor microenvironment dynamics, or neuroinflammation processes, this antibody enables precise and reliable detection of CD38, facilitating the elucidation of its impact on disease progression and therapeutic targeting strategies.In summary, the Human CD38 Monoclonal Antibody (Alexa Fluor 488 Conjugated, HIT2) - AGEL0248 is a powerful research tool for studying the biology of CD38 and its implications in various physiological and pathological conditions. Its fluorescence-conjugated format enhances its utility in imaging and flow cytometry applications, offering researchers a comprehensive solution for investigating CD38-mediated processes in health and disease.